Wells Fargo views the District Court's royalty rate ruling as modest negative for NuVasive, noting that the rates are higher than those used by the jury to calculate lost profits and monetary damages. However, Wells thinks an overhang on shares has now been removed. The firm has a Market Perform rating on the stock.
- Investment & Company Information
- Wells Fargo